Immunogenicity and tolerance following HIV-1/HBV plant-based oral vaccine administration

Vaccine

Volumn 26, Issue 35, 2008, Pages 4477-4485

  Guetard, Denise ^a   Greco, Raffaella ^b   Cervantes Gonzalez, Minerva ^a   Celli, Susanna ^c   Kostrzak, Anna ^a,d   Langlade Demoyen, Pierre ^a   Sala, Francesco ^b   Wain Hobson, Simon ^a   Sala, Monica ^a  

^a CNRS   (France)

^b UNIVERSITY OF MILAN   (Italy)

^c INSTITUT PASTEUR   (France)

^d INSTITUTE OF PLANT GENETICS   (Poland)

Author keywords

HBV; HIV 1; Tolerance; Transgenic plants; Vaccine; VLPs

Indexed keywords

DNA; GAMMA INTERFERON; HEPATITIS B SURFACE ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; TRANSCRIPTION FACTOR FOXP3; VACCINE;

ANIMAL EXPERIMENT; ARTICLE; CD8+ T LYMPHOCYTE; CYTOKINE PRODUCTION; DRUG DELIVERY SYSTEM; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS B VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TOBACCO; TRANSGENIC PLANT; VACCINATION; VACCINE PRODUCTION; VIRUS LIKE AGENT;

ADMINISTRATION, ORAL; AIDS VACCINES; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; EPITOPES; FEMALE; FLOW CYTOMETRY; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HIV-1; IMMUNIZATION, SECONDARY; LYMPH NODES; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBSETS; MICE; PLANTS, GENETICALLY MODIFIED; T-LYMPHOCYTES, REGULATORY; TOBACCO; VACCINES, DNA; VACCINES, EDIBLE; VACCINES, VIROSOME; VIRAL PROTEINS;

EID: 48449103933     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.06.059     Document Type: Article

References (51)

1. Titti F., Cafaro A., Ferrantelli F., Tripiciano A., Moretti S., Caputo A., et al. Problems and emerging approaches in HIV/AIDS vaccine development. Expert Opin Emerg Drugs 12 1 (2007) 23-48
2. Blancou P., Chenciner N., Ho Tsong Fang R., Monceaux V., Cumont M.C., Guetard D., et al. Simian immunodeficiency virus promoter exchange results in a highly attenuated strain that protects against uncloned challenge virus. J Virol 78 3 (2004) 1080-1092
3. Koff W.C., Johnson P.R., Watkins D.I., Burton D.R., Lifson J.D., Hasenkrug K.J., et al. HIV vaccine design: insights from live attenuated SIV vaccines. Nat Immunol 7 1 (2006) 19-23
4. Walmsley S.L., Thorne A., Loutfy M.R., Lapierre N., Macleod J., Harrigan R., et al. A prospective randomized controlled trial of structured treatment interruption in HIV-infected patients failing highly active antiretroviral therapy (Canadian HIV Trials Network Study 164). J Acquir Immune Defic Syndr 45 4 (2007) 418-425
5. Centlivre M., Sala M., Wain-Hobson S., and Berkhout B. In HIV-1 pathogenesis the die is cast since primary infection. AIDS 21 1 (2007) 1-11
6. Sala M., Centlivre M., and Wain-Hobson S. Clade-specific differences in active viral replication and compartimentalization. Curr Opin HIV AIDS 1 2 (2006) 108-114
7. Brenchley J.M., Schacker T.W., Ruff L.E., Price D.A., Taylor J.H., Beilman G.J., et al. CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med 200 6 (2004) 749-759
8. Li Q., Duan L., Estes J.D., Ma Z.M., Rourke T., Wang Y., et al. Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells. Nature 434 7037 (2005) 1148-1152
9. Mattapallil J.J., Douek D.C., Hill B., Nishimura Y., Martin M., and Roederer M. Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature 434 7037 (2005) 1093-1097
10. Mehandru S., Poles M.A., Tenner-Racz K., Horowitz A., Hurley A., Hogan C., et al. Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract. J Exp Med 200 6 (2004) 761-770
11. Mehandru S., Poles M.A., Tenner-Racz K., Manuelli V., Jean-Pierre P., Lopez P., et al. Mechanisms of gastrointestinal CD4+ T-cell depletion during acute and early human immunodeficiency virus type 1 infection. J Virol 81 2 (2007) 599-612
12. Mattapallil J.J., and Roederer M. Acute HIV infection: it takes more than guts. Curr Opin HIV AIDS 1 (2006) 10-15
13. Belyakov I.M., Hel Z., Kelsall B., Kuznetsov V.A., Ahlers J.D., Nacsa J., et al. Mucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaques. Nat Med 7 12 (2001) 1320-1326
14. Belyakov I.M., Kuznetsov V.A., Kelsall B., Klinman D., Moniuszko M., Lemon M., et al. Impact of vaccine-induced mucosal high-avidity CD8+ CTLs in delay of AIDS viral dissemination from mucosa. Blood 107 8 (2006) 3258-3264
15. Smith D.W., and Nagler-Anderson C. Preventing intolerance: the induction of nonresponsiveness to dietary and microbial antigens in the intestinal mucosa. J Immunol 174 7 (2005) 3851-3857
16. Strobel S., and Mowat A.M. Oral tolerance and allergic responses to food proteins. Curr Opin Allergy Clin Immunol 6 3 (2006) 207-213
17. Iwasaki A. Mucosal dendritic cells. Annu Rev Immunol 25 (2007) 381-418
18. Mahnke K., Johnson T.S., Ring S., and Enk A.H. Tolerogenic dendritic cells and regulatory T cells: a two-way relationship. J Dermatol Sci 46 3 (2007) 159-167
19. Mowat A.M. Dendritic cells and immune responses to orally administrated antigens. Vaccine 23 (2005) 1797-1799
20. Yi H., Zhen Y., Jiang L., Zheng J., and Zhao Y. The phenotypic characterization of naturally occurring regulatory CD4+CD25+ T cells. Cell Mol Immunol 3 3 (2006) 189-195
21. Zelenay S., Lopes-Carvalho T., Caramalho I., Moraes-Fontes M.F., Rebelo M., and Demengeot J. Foxp3+ CD25- CD4 T cells constitute a reservoir of committed regulatory cells that regain CD25 expression upon homeostatic expansion. Proc Natl Acad Sci USA 102 11 (2005) 4091-4096
22. Sala F., Rigano M.M., Barbante A., Basso B., Walmsley A.M., and Castiglione S. Vaccine antigene production in transgenic plants: strategies, gene constructs and perspectives. Vaccine 21 (2003) 803-808
23. Thanavala Y., Huang Z., and Mason H.S. Plant-derived vaccines: a look back at the highlights and a view to the challenges on the road ahead. Expert Rev Vaccine 5 2 (2006) 249-260
24. Streatfield S.J. Mucosal immunization using recombinant plant-based oral vaccines. Methods 38 2 (2006) 150-157
25. Michel M., Lone Y.-C., Centlivre M., Roux P., Wain-Hobson S., and Sala M. Optimisation of secretion of recombinant HBsAg virus-like particles: impact on the development of HIV-1/HBV bivalent vaccines. Vaccine 25 (2007) 1901-1911
26. Firat H., Garcia-Pons F., Tourdot S., Pascolo S., Scardino A., Garcia Z., et al. H-2 class I knockout, HLA-A2. 1-transgenic mice: a versatile animal model for preclinical evaluation of antitumor immunotherapeutic strategies. Eur J Immunol 29 10 (1999) 3112-3121
27. Pajot A., Michel M.L., Fazilleau N., Pancre V., Auriault C., Ojcius D.M., et al. A mouse model of human adaptive immune functions: HLA-A2.1-/HLA-DR1-transgenic H-2 class I-/class II-knockout mice. Eur J Immunol 34 11 (2004) 3060-3069
28. Greco R., Michel M., Guetard D., Cervantes-Gonzalez M., Pelucchi N., Wain-Hobson S., et al. Production of recombinant HIV-1/HBV virus-like particles in Nicotiana tabacum and Arabidopsis thaliana plants for a bivalent vaccine. Vaccine 25 (2007) 8228-8240
29. Loirat D., Li Z., Mancini M., Tiollais P., Paulin D., and Michel M.L. Muscle-specific expression of hepatitis B surface antigen: no effect on DNA-raised immune responses. Virology 260 1 (1999) 74-83
30. Buzoni-Gatel D., Debbabi H., Moretto M., Dimier-Poisson I.H., Lepage A.C., Bout D.T., et al. Intraepithelial lymphocytes traffic to the intestine and enhance resistance to Toxoplasma gondii oral infection. J Immunol 162 10 (1999) 5846-5852
31. Mennechet F.J., Kasper L.H., Rachinel N., Minns L.A., Luangsay S., Vandewalle A., et al. Intestinal intraepithelial lymphocytes prevent pathogen-driven inflammation and regulate the Smad/T-bet pathway of lamina propria CD4+ T cells. Eur J Immunol 34 4 (2004) 1059-1067
32. Firat H., Tourdot S., Ureta-Vidal A., Scardino A., Suhrbier A., Buseyne F., et al. Design of a polyepitope construct for the induction of HLA-A0201-restricted HIV 1-specific CTL responses using HLA-A*0201 transgenic, H-2 class I KO mice. Eur J Immunol 31 10 (2001) 3064-3074
33. Pajot A., Michel M.L., Mancini-Bourgine M., Ungeheuer M.N., Ojcius D.M., Deng Q., et al. Identification of novel HLA-DR1-restricted epitopes from the hepatitis B virus envelope protein in mice expressing HLA-DR1 and vaccinated human subjects. Microbes Infect 8 12-13 (2006) 2783-2790
34. Lichterfeld M., Yu X.G., Waring M.T., Mui S.K., Johnston M.N., Cohen D., et al. HIV-1-specific cytotoxicity is preferentially mediated by a subset of CD8(+) T cells producing both interferon-gamma and tumor necrosis factor-alpha. Blood 104 2 (2004) 487-494
35. Kelleher A.D., and Zaunders J.J. Decimated or missing in action: CD4+ T cells as targets and effectors in the pathogenesis of primary HIV infection. Curr HIV/AIDS Rep 3 1 (2006) 5-12
36. Benito J.M., Lopez M., and Soriano V. The role of CD8+ T-cell response in HIV infection. AIDS Rev 6 2 (2004) 79-88
37. Friedrich T.C., Valentine L.E., Yant L.J., Rakasz E.G., Piaskowski S.M., Furlott J.R., et al. Subdominant CD8+ T-cell responses are involved in durable control of AIDS virus replication. J Virol 81 7 (2007) 3465-3476
38. Kapusta J., Modelska A., Figlerowicz M., Pniewski T., Letellier M., Lisowa O., et al. A plant-derived edible vaccine against hepatitis B virus. FASEB J 13 13 (1999) 1796-1799
39. Kapusta J., Modelska A., Pniewski T., Figlerowicz M., Jankowski K., Lisowa O., et al. Oral immunization of human with transgenic lettuce expressing hepatitis B surface antigen. Adv Exp Med Biol 495 (2001) 299-303
40. Shchelkunov S.N., Salyaev R.K., Pozdnyakov S.G., Rekoslavskaya N.I., Nesterov A.E., Ryzhova T.S., et al. Immunogenicity of a novel, bivalent, plant-based oral vaccine against hepatitis B and human immunodeficiency viruses. Biotechnol Lett 28 13 (2006) 959-967
41. Kong Q., Richter L., Yang Y.F., Arntzen C.J., Mason H.S., and Thanavala Y. Oral immunization with hepatitis B surface antigen expressed in transgenic plants. Proc Natl Acad Sci USA 98 20 (2001) 11539-11544
42. Richter L.J., Thanavala Y., Arntzen C.J., and Mason H.S. Production of hepatitis B surface antigen in transgenic plants for oral immunization. Nat Biotechnol 18 11 (2000) 1167-1171
43. Blanas E., Carbone F.R., Allison J., Miller J.F., and Heath W.R. Induction of autoimmune diabetes by oral administration of autoantigen. Science 274 5293 (1996) 1707-1709
44. Blanas E., Davey G.M., Carbone F.R., and Heath W.R. A bone marrow-derived APC in the gut-associated lymphoid tissue captures oral antigens and presents them to both CD4+ and CD8+ T cells. J Immunol 164 6 (2000) 2890-2896
45. Li J.T., Fei L., Mou Z.R., Wei J., Tang Y., He H.Y., et al. Immunogenicity of a plant-derived edible rotavirus subunit vaccine transformed over fifty generations. Virology 356 1-2 (2006) 171-178
46. Radcliffe J.N., Roddick J.S., Stevenson F.K., and Thirdborough S.M. Prolonged antigen expression following DNA vaccination impairs effector CD8+ T cell function and memory development. J Immunol 179 12 (2007) 8313-8321
47. Mason H.S., Lam D.M., and Arntzen C.J. Expression of hepatitis B surface antigen in transgenic plants. Proc Natl Acad Sci USA 89 24 (1992) 11745-11749
48. Huang Z., Elkin G., Maloney B.J., Beuhner N., Arntzen C.J., Thanavala Y., et al. Virus-like particle expression and assembly in plants: hepatitis B and Norwalk viruses. Vaccine 23 15 (2005) 1851-1858
49. Smith M.L., Mason H.S., and Shuler M.L. Hepatitis B surface antigen (HBsAg) expression in plant cell culture: kinetics of antigen accumulation in batch culture and its intracellular form. Biotechnol Bioeng 80 7 (2002) 812-822
50. Kozak M. Pushing the limits of the scanning mechanism for initiation of translation. Gene 299 1-2 (2002) 1-34
51. Lukaszewicz M., Feuermann M., Jerouville B., Stas A., and Boutry M. In vivo evaluation of the context sequence of the translation initiation codon in plants. Plant Sci 154 1 (2000) 89-98